12:00 AM
Feb 16, 2015
 |  BioCentury  |  Finance

Atlanta angels

How new Atlanta angel group plans to invest in life sciences

Bio/Med Investor Network plans to invest $200,000-$2 million per company in biotech, medtech and digital health plays not yet ready for venture capital. But while the new Atlanta angel network arose out of a need to serve Georgia companies, the network does not have geographic restrictions for investments or members.

Georgia Bio President and CEO Russell Allen said the trade group and the Georgia Research Alliance (GRA) began exploring how to organize accredited investors in the region who were also...

Read the full 386 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >